Skip to main content

Bezlotoxumab reduces CDI recurrence across antibiotic subgroups

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Bezlotoxumab reduces CDI recurrence across antibiotic subgroups

User login

Username

Password

Reset your password

Type	Lead	score